Boston Scientific Corp. (NYSE:BSX) Q2 2018 Earnings Call July 25, 2018 8:00 AM ET
Executives
Susan Vissers Lisa - Boston Scientific Corp.
Michael F. Mahoney - Boston Scientific Corp.
Daniel J. Brennan - Boston Scientific Corp.
Ian T. Meredith - Boston Scientific Corp.
Kenneth Stein, M.D. - Boston Scientific Corp.
Analysts
David Ryan Lewis - Morgan Stanley & Co. LLC
Glenn John Novarro - RBC Capital Markets LLC
Frederick Wise - Stifel, Nicolaus & Co., Inc.
Lawrence Biegelsen - Wells Fargo Securities LLC
Joanne Karen Wuensch - BMO Capital Markets (United States)
Robert J. Marcus - JPMorgan Securities LLC
Christopher Pasquale - Guggenheim Securities LLC
Bruce M. Nudell - SunTrust Robinson Humphrey, Inc.
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the Boston Scientific Q2 2018 earnings call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Instructions will be given at that time. As a reminder, today's call is being recorded.
I will now turn the conference over to your host, Susan Lisa. Please go ahead.
Susan Vissers Lisa - Boston Scientific Corp.
Thank you, Kevin. Good morning, everyone, and thanks for joining us. With me on today's call are Mike Mahoney, Chairman and Chief Executive Officer, and Dan Brennan, Executive Vice President and Chief Financial Officer.
We issued a press release earlier this morning announcing our Q2 2018 results, which included reconciliations of the non-GAAP measures used in the release. We have posted a copy of that release as well as reconciliations of the non-GAAP measures used in today's call to the Investor Relations section of our website under the heading Financial Information.

